D. Mu

发表

A microRNA polycistron as a potential human oncogene

S. Lowe, J. M. Thomson, S. Hammond, 2005, Nature.

The gene encoding the splicing factor SF2/ASF is a proto-oncogene

A. Krainer, S. Lowe, E. Stanchina, 2007, Nature Structural &Molecular Biology.

Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations.

Kathleen R. Cho, Rork Kuick, Rong Wu, 2008, Neoplasia.

Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic Approach

M. Wigler, R. Lucito, S. Lowe, 2006, Cell.

The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers

T. Ørntoft, C. Andersen, D. Mu, 2013, The Journal of pathology.

Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer

Jude Kendall, B. Lakshmi, A. Krasnitz, 2007, Proceedings of the National Academy of Sciences.

Occludin Is a Direct Target of Thyroid Transcription Factor-1 (TTF-1/NKX2–1)*

D. Mu, D. Antonetti, M. Winslow, 2012, The Journal of Biological Chemistry.

MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1

Anna C. Salzberg, D. Mu, J. Liao, 2012, Cell cycle.

D. Mu, S. Powers, 2008, Cell cycle.

Oncogenic potential of TASK3 (Kcnk9) depends on K+ channel function

L. Jan, D. Mu, S. Powers, 2003, Proceedings of the National Academy of Sciences of the United States of America.

CD14, a key candidate gene associated with a specific immune response to cockroach

A. Togias, D. Mu, C. Cheadle, 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Connecting Cholesterol Efflux Factors to Lung Cancer Biology and Therapeutics

D. Mu, Maria Maslyanko, Ryan D. Harris, 2021, International journal of molecular sciences.

Tight junction proteins: from barrier to tumorigenesis.

D. Mu, E. A. Runkle, 2013, Cancer letters.

Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene.

M. Wigler, L. Jan, S. Lowe, 2003, Cancer cell.

Cooperation between Rb and Arf in suppressing mouse retinoblastoma.

D. Mu, D. MacPherson, S. Mukai, 2012, The Journal of clinical investigation.

Two Distinct Categories of Focal Deletions in Cancer Genomes

Kathleen R. Cho, Michael Ruogu Zhang, A. Krasnitz, 2013, PloS one.

Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model

D. Mu, S. Powers, S. Orsulic, 2008, International journal of cancer.

Murine bilateral retinoblastoma exhibiting rapid‐onset, metastatic progression and N‐myc gene amplification

T. Jacks, D. Mu, D. MacPherson, 2007, The EMBO journal.

Roles of Thyroid Transcription Factor 1 in Lung Cancer Biology.

D. Mu, S. Lai, Cody A. Phelps, 2018, Vitamins and hormones.

MicroRNA-33a Mediates the Regulation of High Mobility Group AT-Hook 2 Gene (HMGA2) by Thyroid Transcription Factor 1 (TTF-1/NKX2–1)*

Monte M Winslow, D. Mu, M. Winslow, 2013, The Journal of Biological Chemistry.

The Complexity of Thyroid Transcription Factor 1 with Both Pro- and Anti-oncogenic Activities*

D. Mu, 2013, The Journal of Biological Chemistry.

MicroRNAs and lung cancers: from pathogenesis to clinical implications

D. Mu, Ji Qi, 2012, Frontiers of Medicine.

Thyroid Transcription Factor 1 Reprograms Angiogenic Activities of Secretome

D. Mu, S. Lai, C. Talbot, 2016, Scientific Reports.

Gene Mutations and Genomic Rearrangements in the Mouse as a Result of Transposon Mobilization from Chromosomal Concatemers

L. Leinwand, R. Lucito, S. Lowe, 2006, PLoS genetics.

Mechanistic Study of TTF-1 Modulation of Cellular Sensitivity to Cisplatin

D. Mu, A. Sancar, L. Lindsey-Boltz, 2019, Scientific Reports.

Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer.

Katherine S. Lovejoy, T. Golub, A. Subramanian, 2010, Genes & development.

tumor progression in a mouse model of lung cancer Chronic cisplatin treatment promotes enhanced damage repair and Material

Katherine S. Lovejoy, T. Golub, A. Subramanian, 2010 .

CRISPR-Induced Loss of Connexin 43 Expression Sensitizes KRAS Mutant Cells to Cisplatin

D. Mu, Stephen Martin, 2022, microPublication biology.

Identification of alterations in DNA copy number in host stromal cells during tumor progression

David Botstein, Robert Lucito, Michael Wigler, 2006, Proceedings of the National Academy of Sciences.

miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma.

J. M. Thomson, S. Hammond, D. Mu, 2011, Genes & development.

Mnk2 alternative splicing modulates the p38-MAPK pathway and impacts Ras-induced transformation.

T. Ørntoft, C. Andersen, D. Mu, 2014, Cell reports.

Role of the chromobox protein CBX7 in lymphomagenesis

S. Lowe, T. Visakorpi, D. Mu, 2007, Proceedings of the National Academy of Sciences.

Characterizing the developmental pathways TTF-1, NKX2–8, and PAX9 in lung cancer

H. Dressman, J. Nevins, Sayan Mukherjee, 2009, Proceedings of the National Academy of Sciences.

Thyroid transcription factor 1 enhances cellular statin sensitivity via perturbing cholesterol metabolism

D. Mu, S. Lai, Aleena M Short, 2018, Oncogene.

F2 Isoprostane Levels in Plasma and Urine do not Support Increased Lipid Peroxidation in Cognitively Impaired Parkinson Disease Patients

C. Clark, D. Mu, A. Siderowf, 2008, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

Mechanistic Study of TTF-1 Modulation of Cellular Sensitivity to Cisplatin

D. Mu, A. Sancar, L. Lindsey-Boltz, 2019, Scientific Reports.

Loss of Gap Junction Factor Connexin 43 Results in an Increase of Exosomal Tetraspanins in Human Lung Cancer Cell Line A549

D. Mu, Edward P Si, Ariel B Flotte, 2022, microPublication biology.